The recent Ketamine Provider Survey, which closed on June 1, 2024, conducted by Advaya Health and Wellness with the support of  Psytelligence provides keen  insights into the operational landscape, challenges, and future aspirations of ketamine therapy providers.  With responses from 25 practitioners the survey highlights the diverse services offered, the range of conditions treated, and […]

Psytelligence “Ask the Experts” Event – Video and Summary The landscape of psychedelic therapy is rapidly evolving, presenting unique opportunities and challenges for practitioners. To help navigate this complex field, a recent event brought together three experts to share their insights on enhancing psychedelic therapy practices. This article summarizes their advice, providing a comprehensive guide for therapists looking to expand their practice legally, […]

Psychedelic Therapy Finance Expert: Jeffrey Krepps, Co-Founder, Advaya Health and Wellness

Jeffrey Krepps is a seasoned mental health therapist and finance expert with over 20 years of experience in developing healthcare organizations. As Co-Founder and Chief Business Development Officer at Advaya Health and Wellness, Jeffrey has played a pivotal role in creating financial strategies that ensure the sustainability and growth of healthcare practices, particularly those specializing in […]

Psychedelic Marketing Expert: Steen Beck, Media Director, Tricycle Day

Steen Beck is the dynamic Media Director at Tricycle Day, a leading platform in the psychedelic industry known for its innovative marketing strategies and engaging content. Steen’s career, spanning over a decade, has positioned him as a key figure in promoting psychedelic therapy practices and expanding the reach of these transformative treatments. Steen holds a […]

Psytelligence Legal Expert: Natasha Sumner, Senior Counsel, Husch Blackwell Law Firm

Natasha Sumner is a leading authority in the field of psychedelic therapy law, serving as Senior Counsel at Husch Blackwell. She co-leads the firm’s groundbreaking Psychedelics and Emerging Therapies Practice Group, which is dedicated to navigating the legal complexities of psychedelic substances in clinical and therapeutic settings. With a career that spans over two decades, […]

Psytelligence Presents: “Ask the Experts” Event

Date: June 21st, 2024 Time: 10-11:30amPT / 1-2:30pmET Format: Free Online Panel Discussion Join us for the Psytelligence “Ask the Experts” Event where Psychedelic Therapists can get answers about legal, finance, and marketing! Event Overview Are you a psychedelic therapist navigating the complex landscape of running a successful practice? Join us for a special “Ask […]

The FDA is Addicted to Drugs

The FDA’s recent review of MDMA-assisted therapy for PTSD has highlighted a critical flaw within the organization: its addiction to drugs. The FDA’s regulatory framework is so narrowly focused on pharmacological interventions that it cannot effectively comprehend, much less regulate, treatments that combine drugs with psychotherapy. This addiction not only stymies innovative therapies but also […]

Ensuring Your Psychedelic Therapy Reaches Those in Need

As a psychedelic therapist, your mission is to provide transformative healing to those suffering from mental health challenges. However, to fulfill this mission, you need to ensure that your services reach the people who need them most. In today’s digital age, optimizing your marketing strategies is crucial for expanding your reach and connecting with potential […]

Building a Sustainable Psychedelic Therapy Practice Helps More People

Struggling with finances? Secure your psychedelic therapy practice to open doors for more clients. Financial stability is crucial for any successful practice, and psychedelic therapy is no exception. A well-planned financial strategy not only ensures the longevity of your practice but also enhances accessibility for those who need your services the most. Let’s delve deeper […]

The Critical Role of Intake in Psychedelic Therapy: Ensuring Safety and Efficacy

Psychedelic therapy is emerging as a transformative tool in mental health treatment, promising significant improvements for conditions such as depression, PTSD, and anxiety. However, the success and safety of these treatments hinge crucially on a well-conducted intake process. This initial stage sets the foundation for personalized care and risk mitigation, making it a cornerstone of […]